RELAPSING-REMITTING MULTIPLE SCLEROSIS

This study is testing whether a stem cell transplant can better control multiple sclerosis (MS) than the best available drugs in people whose MS stays active despite treatment. It will involve 156 adults whose MS has flared up despite taking strong medications. Participants will …

This study is testing whether a small device implanted in the neck can help repair the protective coating around nerves (myelin) in people with relapsing-remitting multiple sclerosis (RRMS). The device delivers mild electrical stimulation to the vagus nerve. Up to 60 participants…

This study aims to find out if an older, less expensive drug called rituximab works just as well as a newer, much more expensive drug called ocrelizumab for controlling relapsing multiple sclerosis (MS). About 386 adults with active relapsing MS will be randomly assigned to recei…

This early-stage study is checking if a drug called ixazomib, used for a type of blood cancer, is safe for people with multiple sclerosis (MS). The goal is to see if it can reduce harmful antibodies linked to MS in the fluid around the brain and spine. About 72 participants with …

This study is testing whether two specific diet plans, followed by a period of calorie restriction for weight loss, can improve daily life for people with multiple sclerosis. One hundred adults with MS will follow either a low-glycemic or standard diet for 32 weeks, with free gro…

This study is testing a new digital platform designed to help doctors better monitor and manage people with relapsing-remitting multiple sclerosis (MS). The platform includes an app for patients to track their health and a system for doctors to analyze brain scans using artificia…

This study aims to understand why certain effective MS therapies continue to work long after treatment. Researchers will closely follow 100 people with relapsing-remitting MS who are taking specific B-cell targeting drugs. They will collect detailed health data and blood samples …